# Management of Phlegmasia Cerulea Dolens Alongside Neurologic Contraindication to Anticoagulation: A Therapeutic and Diagnostic Dilemma

## TL;DR

This case report discusses the challenges of managing a rare blood clot condition in a patient with a recent stroke.

## Contribution

It presents a viable approach for delayed anticoagulation after neurological clearance in a complex clinical scenario.

## Key findings

- Delayed anticoagulation can be considered after neurological clearance in select cases.
- Balancing thrombotic progression and hemorrhagic risk is crucial in such patients.

## Abstract

The purpose of this case report is to highlight anticoagulation management of phlegmasia cerulea dolens, particularly in a patient with a recent ischemic stroke that underwent hemorrhagic transformation. In select cases, delayed anticoagulation after appropriate neurological clearance can be a viable approach to prevent thrombotic progression while minimizing hemorrhagic risk.